• 1

    Holick M: Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. .Am J Clin Nutr 79::362. ,2004. .

  • 2

    Morgan S: Calcium and vitamin D in osteoporosis. .Rheum Dis Clin North Am 27::101. ,2001. .

  • 3

    Guyton AC, Hall JE: Textbook of Medical Physiology, 10th Ed, WB Saunders, Philadelphia. ,2000. .

    • PubMed
    • Export Citation
  • 4

    Lyman D: Undiagnosed vitamin D deficiency in the hospitalized patient. .Am Fam Physician 71::299. ,2005. .

  • 5

    Utiger RD: The need for more vitamin D. .N Engl J Med 338::828. ,1998. .

  • 6

    Dawson-Hughes B, Harris SS, Krall EA, et al: Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. .N Engl J Med 337::670. ,1997. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    Thomas MK, Lloyd-Jones DM, Thadhani RI, et al: Hypovitaminosis D in medical inpatients. .N Engl J Med 338::777. ,1998. .

  • 8

    Chapuy MC, Arlot ME, Duboeuf F, et al: Vitamin D3 and calcium to prevent hip fractures in elderly women. .N Engl J Med 327::1637. ,1992. .

  • 9

    Genuth SM: “Endocrine regulation of the metabolism of calcium and related minerals,” in Principles of Physiology, 2nd Ed, ed by RM Berne, MN Levy, p 625, Mosby-Year Inc, St. Louis. ,1996. .

    • PubMed
    • Export Citation
  • 10

    Vieth R, Ladak Y, Walfish PG: Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. .J Clin Endocrinol Metab 88::185. ,2003. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11

    Sanders LJ, Frykberg RG: “The Charcot Foot,” in The High Risk Foot in Diabetes Mellitus, ed by RG Frykberg, p 325, Churchill Livingstone, New York. ,1991. .

    • PubMed
    • Export Citation
  • 12

    Kroop SF, Simon LS: “Joint and bone manifestations of diabetes mellitus” in Joslin’s Diabetes, 13th Ed, ed by CR Kahn, GC Weir, p 912, Lea & Febiger, Philadelphia. ,1994. .

    • PubMed
    • Export Citation
  • 13

    Brower A, Allman R: Pathogenesis of the neurotrophic joint: neurotraumatic vs. .neurovascular. Diagn Radiol 139::349. ,1981. .

  • 14

    Llach F, Bover J: “Renal Osteodystropies,” in Brenner and Rector’s The Kidney, 6th Ed, ed by BB Brenner, p 2103, WB Saunders, Philadelphia. ,2000. .

    • PubMed
    • Export Citation
  • 15

    Sanders LJ, Frykberg RG: “Charcot neuroarthropathy of the foot” in Levin and O’Neals’s The Diabetic Foot, 6th Ed, ed by JH Bowker, MA Pfeifer, St. Louis. ,2001. .

    • PubMed
    • Export Citation
  • 16

    Eichenholtz, SN: Charcot Joints, ed by DD Thomas, Charles C Thomas, Springfield, IL. ,1966. .

    • PubMed
    • Export Citation
  • 17

    Steingrimsdottir L, Gunnarsson O, Indridason I, et al: Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. .JAMA 294::2336. ,2005. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18

    Sigurdsson G, Franzson L, Steingrimsdottir L, et al: The association between parathyroid hormone, vitamin D and bone mineral density in 70-year-old Icelandic women. .Osteoporos Int 11::1031. ,2000. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19

    Malabanan A, Veronkis IE, Holick MF: Redefining vitamin D insufficiency. .Lancet 351::805. ,1998. .

  • 20

    McNair P, Madsbad S: Bone mineral loss in insulin-treated diabetes mellitus: studies on the pathogenesis. .Acta Endocrinol 90::463. ,1979. .

  • 21

    McNair P, Madsbad S, Christensen C: Bone loss in diabetics: effect of metabolic state. .Diabetologia 17::283. ,1979. .

  • 22

    Hui SL, Epstein S, Johnston CC: A prospective study of bone mass in patients with type I diabetes. .J Clin Endrocrinol Metab 60::74. ,1985. .

  • 23

    Suzuki A, Kotake M, Ono Y, et al: Hypovitaminosis D in type 2 diabetes mellitus: association with microvascular complications and type of treatment. .Endocr J 53::503. ,2006. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24

    Forsen L, Meyer HE, Midthjell K, et al: Diabetes mellitus and the incidence of hip fracture: results from Nord Trondelag Health Survey. .Diabetologia 42::920. ,1999. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25

    Ivers RQ, Cumming RG, Mitchell P, et al: Diabetes and risk of fracture: the Blue Mountains eye study. .Diabetes Care 24::1198. ,2001. .

  • 26

    Ledig-Bruckner G, Ziegler R: Diabetes mellitus a risk for osteoporosis? Exp Clin Endocrinol Diabetes 109: S493. ,2001. .

    • Crossref
    • PubMed
    • Export Citation
  • 27

    Trivedi DP, Doll R, Khaw KT: Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomized double blind controlled trial. .BMJ 326::1621. ,2003. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28

    Baynes JW: From life to death–the struggle between chemistry and biology during aging: the Maillard reaction as an amplifier of genomic damage. .Biogerontology 1::235. ,2000. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 29

    Monnier VM: Toward a Malliard reaction theory of aging. .Prog Clin Biol Res 304::1. ,1989. .

  • 30

    Vlassara H, Bucala R, Striker L: Pathogenic effects of advanced glycosylation: biochemical, biological, and clinical implications for diabetes and aging. .Lab Invest 70::138. ,1994. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 31

    Valcourt U, Merle B, Gineyts E, et al: Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation. .J Biol Chem 282::5691. ,2007. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32

    Katayama Y, Celic S, Nagata N, et al: Nonenzymatic glycation of type I collagen modifies interaction with UMR 201-10B preosteoblastic cells. .Bone 21::327. ,1997. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 33

    McCarthy AD, Etcheverry SB, Cortizo AM: Advanced glycation end product specific receptors in rate and mouse osteoblastic-like cells: regulation with stages of differentiation. .Acta Diabetol 36::45. ,1999. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 34

    McCarthy AD, Etcheverry SB, Bruzzone L, et al: Nonenzymatic glycosylation of a type I collagen matrix: effects on osteoblastic development and oxidative stress. .BMC Cell Biol 2::16. ,2001. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35

    Kume S, Kato S, Yamagishi S, et al: Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone. .J Bone Miner Res 20::1647. ,2005. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 36

    McCarthy AD, Uemura T, Etcheverry SB, et al: Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix. .Int J Biochem Cell Biol 36::840. ,2004. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 37

    Heaney RP: Bone health. .Am J Clin Nutr 85::300S. ,2007. .

  • 38

    Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al: Higher 25-hydroxyvitamin D concentrations are associated with better lower extremity function in both active and inactive persons aged ≥ 60y. .Am J Clin Nutr 80::752. ,2004. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 39

    Wicherts IS, Van Schoor NM, Boeke AJP, et al: Vitamin D deficiency and neuromuscular performance in the Longitudinal Aging Study Amsterdam (LASA). .J Bone Miner Res 20::S35. ,2005. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 40

    Grant WP, Foreman EJ, Wilson AS, et al: Evaluation of Young’s modulus in Achilles tendons with diabetic neuroarthropathy. .JAPMA 95::242. ,2005. .

A Comparison of Vitamin D Levels in Nondiabetic and Diabetic Patient Populations

Robert M. Yoho College of Podiatric Medicine and Surgery, Des Moines University, Des Moines, IA.

Search for other papers by Robert M. Yoho in
Current site
Google Scholar
PubMed
Close
 DPM, MS
,
Jill Frerichs College of Podiatric Medicine and Surgery, Des Moines University, Des Moines, IA.

Search for other papers by Jill Frerichs in
Current site
Google Scholar
PubMed
Close
 DPM
,
Nicholas B. Dodson West Penn Hospital, Pittsburgh, PA.

Search for other papers by Nicholas B. Dodson in
Current site
Google Scholar
PubMed
Close
 DPM
,
Robert Greenhagen Division of Health Management, Des Moines University, Des Moines, IA. Dr. Greenhagan is now with the University of Pittsburgh Medical Center, Pittsburgh, PA.

Search for other papers by Robert Greenhagen in
Current site
Google Scholar
PubMed
Close
 DPM
, and
Simon Geletta College of Health Sciences, Des Moines University, Des Moines, IA.

Search for other papers by Simon Geletta in
Current site
Google Scholar
PubMed
Close
 PhD

Background: This study was designed to compare the vitamin D levels in a cohort of nondiabetic patients to populations of diabetic patients with and without Charcot neuroarthropathy.

Methods: A total of 41 participants (22 male, 19 female) with a mean ± SD age of 59 ± 9.43 years had serum 25-hydroxyvitamin D levels tested. Fifteen participants composed the nondiabetic group; 13, the group with diabetes but without Charcot neuroarthropathy; and 13, the group with both diabetes and Charcot neuroarthropathy.

Results: The results of the study showed that the vitamin D levels in both diabetic populations were significantly lower (P < .05) than the nondiabetic population. There was no statistical difference between the group with diabetes but without Charcot foot disease and the group with both diabetes and Charcot neuroarthropathy.

Conclusions: Based on the results of this study, given the importance of vitamin D in bone metabolism and the osseous consequences associated with diabetes, as well as other systems affected by low levels of vitamin D in the diabetic patient, it appears that vitamin D levels should be monitored in diabetic patients. (J Am Podiatr Med Assoc 99(1): 35–41, 2009)

Corresponding author: Robert M. Yoho, DPM, MS, College of Podiatric Medicine and Surgery, Des Moines University, 3200 Grand Ave, Des Moines, IA 50312. (E-mail: robert.yoho@dmu.edu)
Save